» Authors » Sara Iranparast

Sara Iranparast

Explore the profile of Sara Iranparast including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 118
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vahabi M, Rostamian A, Mirsharif E, Latifi K, Iranparast S, Ghazanfari T
Iran J Allergy Asthma Immunol . 2025 Mar; 24(1):21-30. PMID: 40052886
COVID-19 is capable of undermining self-tolerance in a host's immune system and triggering autoimmunity by hyper-activating the innate and adaptive immune systems, which has not investigated in Iranian society until...
2.
Shohan M, Mahmoudian-Sani M, Saeedi-Boroujeni A, Iranparast S, Nashibi R, Abolnezhadian F, et al.
J Interferon Cytokine Res . 2024 May; 44(7):316-324. PMID: 38738802
As an antibody-based therapy, plasma therapy has been used as an emergency therapeutic strategy against severe acute respiratory syndrome coronavirus type 2 infection. Due to the critical role of macrophages...
3.
Abolnezhadian F, Iranparast S, Shohan M, Shokati Eshkiki Z, Hamed M, Seyedtabib M, et al.
Heliyon . 2024 Apr; 10(7):e28528. PMID: 38590857
Background: Severe acute respiratory syndrome coronavirus 2 was first reported in December 2019 and it has spread globally ever since. The HLA system is crucial in directing anti-viral immunity and...
4.
Abolnezhadian F, Aminzadeh M, Iranparast S, Dehnavi S, Dousti F, Sharifat M, et al.
Iran J Allergy Asthma Immunol . 2024 Mar; 23(1):115-121. PMID: 38485906
Sanjad Sakati Syndrome (SSS) is categorized as a neuroendocrine-related disease due to disorders of the nervous and hormonal systems. Since hormonal changes in these patients may affect the nature and...
5.
Sadeghi M, Mohammadi M, Tavakol Afshari J, Iranparast S, Ansari B, Dehnavi S
Cell Immunol . 2024 Feb; 397-398:104813. PMID: 38364454
Due to their immunomodulatory capacities, mesenchymal stem cells (MSCs) have been extensively used as therapeutic approaches in cell-based therapy for various inflammatory diseases. Several lines of studies have shown that...
6.
Iranparast S, Tahmasebi-Birgani M, Motamedfar A, Amari A, Ghafourian M
J Res Med Sci . 2023 May; 28:32. PMID: 37213455
Background: is a key player in inflammatory reactions, carcinogenesis, and tumor development. In this study, polymorphism of and its gene and suppressor of cytokine signaling-1 (SOCS-1) expression were investigated in...
7.
Nabavizadeh S, Moghtaderi M, Alyasin S, Esmaeilzadeh H, Teshnizi S, Jabbari-Azad F, et al.
Med J Islam Repub Iran . 2023 Jan; 36:128. PMID: 36620471
It is well established that upper and lower airways are often clumped together when diagnosing and treating a disease. This study was designed to determine the prevalence of upper and...
8.
Khodadadi A, Ghadiri A, Ghafourian M, Iranparast S, Najaan M
J Family Reprod Health . 2022 Dec; 16(3):205-211. PMID: 36569261
Worldwide, preeclampsia (PE) is a multifactorial disorder reported in 2-5% of pregnancies, which increases mortality during pregnancy. In general, 10-15% of maternal deaths are directly related to PE and eclampsia....
9.
Tavakol M, Delavari S, Salami F, Ansari S, Rasouli S, Chavoshzadeh Z, et al.
Allergy Asthma Clin Immunol . 2022 Dec; 18(1):106. PMID: 36510326
Genetic defects in the development, maturation, and/or function of the immune cells can lead to Inborn errors of immunity (IEI) which may predispose patients to malignancies. The overall risk for...
10.
Abolhassani H, Delavari S, Landegren N, Shokri S, Bastard P, Du L, et al.
J Allergy Clin Immunol . 2022 Sep; 150(5):1059-1073. PMID: 36113674
Background: Most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected individuals are asymptomatic or only exhibit mild disease. In about 10% of cases, the infection leads to hypoxemic pneumonia, although it...